glp 1 and cancer Glucagon-like peptide receptor agonists risk: advancing precision medicine through mechanistic understanding and clinical evidence | Biomarker Research GLP-1s may reduce cancer risk
Description
According to the CDC, obesity remains one of the strongest modifiable risk factors for osteoarthritis progression
[00:29:00] We have to protect our muscle mass
The effect size differs by roughly an order of magnitude
Therefore, the risk of cholelithiasis is postulated to be related to GLP1-RAs rather than T2D
